CoPharma licenses RC.552 from Corixa

CoPharma (Hopkinton, Mass.) obtained an exclusive license in territories including the U.S., Europe, and Japan to develop and commercialize RC.552, an aminoalkyl glucosaminide 4-phosphate, to treat or...